Fuso Pharmaceutical Industries, Ltd. (4538) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Fuso Pharmaceutical Industries, Ltd. (4538:JPX), powered by AI.

Current Price
¥2,057
P/E Ratio
-5.3
Market Cap
17.6B
Sector
Healthcare
What is the Fuso Pharmaceutical Industries, Ltd. stock price forecast?

Fuso Pharmaceutical Industries, Ltd. is currently trading at ¥2,057. View real-time AI analysis on Alpha Lenz.

What is Fuso Pharmaceutical Industries, Ltd. insider trading activity?

View the latest insider trading data for Fuso Pharmaceutical Industries, Ltd. on Alpha Lenz.

What is Fuso Pharmaceutical Industries, Ltd.'s P/E ratio?

Fuso Pharmaceutical Industries, Ltd.'s P/E ratio is -5.3.

Fuso Pharmaceutical Industries, Ltd.

JPX · 4538
¥2,057+18(+0.88%)Market closedJPX regular session 09:00–15:00 JST
Ask about Fuso Pharmaceutical Industries, Ltd.'s future dividend policy...
Alpha Chat Insight

Fuso Pharmaceutical Industries, Ltd. trades at a P/E of -5.3 (undervalued) with modest ROE of -9.4%.

Ask for details

Company Overview

Fuso Pharmaceutical Industries, Ltd. is a well-established company engaged in the research, development, manufacturing, and distribution of pharmaceuticals and medical products. Headquartered in Japan, Fuso focuses on producing a diverse range of pharmaceutical products including ethical drugs, generic drugs, and over-the-counter medications. The company is committed to advancing healthcare solutions that meet the evolving needs of global communities. Fuso Pharmaceutical serves various sectors, including hospitals, clinics, and pharmacies, providing essential medications that contribute to the broader healthcare ecosystem. The organization's role in the pharmaceutical industry is significant, as it aligns its operational strategies with advancements in medical technology to enhance patient care and therapeutic outcomes. By maintaining high standards in production and ensuring compliance with rigorous quality controls, Fuso Pharmaceutical Industries continues to play a vital role in the global healthcare market.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,370

Company Statistics

FY 2025

Profile

¥17,572,058,262Market Cap
¥60,562,000,000Revenue
0.00Shares Out
1,370Employees

Margins

27.30%Gross
10.42%EBITDA
6.82%Operating
-8.21%Pre-Tax
-5.43%Net

Valuation

-5.34P/E
0.53P/B
0.29EV/Sales
5.17EV/EBITDA
-2.74P/FCF

Growth (CAGR)

6.86%Rev 3Yr
5.25%Rev 5Yr
29.01%Op Inc 3Yr
32.51%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-4.17%ROA
-9.43%ROE
-6.11%ROIC

Financial Health

¥6,264,000,000Cash & Cash Equivalents
¥42,422,000,000Net Debt
147.34%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Fuso Pharmaceutical Industries, Ltd. (ticker: 4538) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,370 employees. Market cap is $17.6B.

The current price is 2,057 with a P/E ratio of -5.34x and P/B of 0.53x.

ROE is -9.43% and operating margin is 6.82%. Annual revenue is $60.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Fuso Pharmaceutical Industries, Ltd. (4538) Stock Forecast 2026 ¥2,057 — Price, Financials & Analyst Targets | Alpha Lenz